Citi Assumes Calithera Biosciences (CALA) at Buy
Tweet
Share
E-mailGet Alerts CALA Hot Sheet
Price: $0.00 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
Citi analyst Mohit Bansal assumes coverage on Calithera Biosciences (NASDAQ: CALA) with a Buy rating and a price target of $10.00 (from $7.00).
For an analyst ratings summary and ratings history on Calithera Biosciences click here. For more ratings news on Calithera Biosciences click here.
Shares of Calithera Biosciences closed at $5.54 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Craig-Hallum Starts Alterity Therapeutics (ATHE) at Buy
- UBS Starts Amcor Plc. (AMCR) at Buy
- Citizens Downgrades ACV Auctions Inc (ACVA) to Market Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
